Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.
- Products
-
- chlorproMAZINE Hydrochloride Tablets
- Where it was sold
-
Nationwide in the USA and PR
Nationwide
- Units affected
- 8160 bottles
- About this recall
- chlorproMAZINE Hydrochloride Tablets, USP 100 mg, Rx Only, 100 Tablets per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-864-01